[Viferon suppositoria in therapy of relapsing herpesvirus infection in women].
The therapeutic efficacy of Viferon, a recombinant human interferon alpha-2b (rectal suppositoria) was studied in the therapy of relapsing herpesvirus infection in women. The clinical efficacy of the drug was recorded in 90% of the patients. The analysis of the remote results of the treatment made it possible to conclude that the Viferon suppositoria had an antirelapsing activity.
Vasil'ev
A N
AN
Kagramanova
Zh A
ZhA
Malinovskaia
V V
VV
Parfenov
V V
VV
D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D006566:Herpesviridae Infections / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000494:pharmacology*; D008875:Middle Aged; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins